January 7, 2013
Roche may have walked away from Illumina for good.
August 31, 2012
Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer rally.
November 30, 2011
It may be time to consider Life Tech as a good blue-chip play in the health-care sector.
October 10, 2011
Illumina and competitors get hit by weak academic spending. Optimism remains, however, with the pull of new and exciting ...
August 4, 2011
Illumina's sky-high valuation takes a beating on lower guidance.
July 7, 2011
Affymetrix continues to flounder with unexciting technology.
April 29, 2011
Illumina is a torrid grower, and growth investors seem to be willing to pay any price.